PrecisionMed Inc. Announces Longitudinal Alzheimer’s Disease Spinal Fluid Biological SAMPLE Registry

SAN DIEGO--(BUSINESS WIRE)--PrecisionMed Inc. today announced enrollment of the first subject into THE SAMPLE REGISTRY (Serial Alzheimer’s Disease and MCI Prospective Longitudinal Evaluation). The SAMPLE Registry is a biological sample bank of DNA and serial RNA, CSF, serum and plasma associated with serial cognition testing utilizing PrecisionMed’s clinical sample and data procurement and storage capabilities.

MORE ON THIS TOPIC